Trials / Sponsors / Daishi Tian
Daishi Tian
Academic / Other · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis. Multiple Sclerosis (MS) | Phase 1 | 2026-04-07 |
| Recruiting | This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple S Multiple Sclerosis | EARLY_Phase 1 | 2026-01-16 |
| Recruiting | CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases Relapsing or Refractory Multiple Sclerosis (MS), Myasthenia Gravis (MG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | EARLY_Phase 1 | 2025-12-12 |
| Recruiting | GC012F Injection in Refractory Idiopathic Inflammatory Myopathy Idiopathic Inflammatory Myopathy (IIM) | EARLY_Phase 1 | 2025-09-15 |
| Recruiting | GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) Generalized Myasthenia Gravis (gMG) | EARLY_Phase 1 | 2025-07-15 |